JP2009500298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009500298A5 JP2009500298A5 JP2008517193A JP2008517193A JP2009500298A5 JP 2009500298 A5 JP2009500298 A5 JP 2009500298A5 JP 2008517193 A JP2008517193 A JP 2008517193A JP 2008517193 A JP2008517193 A JP 2008517193A JP 2009500298 A5 JP2009500298 A5 JP 2009500298A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- sequence
- composition
- linker
- isolated polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69057405P | 2005-06-15 | 2005-06-15 | |
| US60/690,574 | 2005-06-15 | ||
| PCT/US2006/023672 WO2006138675A2 (en) | 2005-06-15 | 2006-06-15 | Her-2 peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012093680A Division JP5542865B2 (ja) | 2005-06-15 | 2012-04-17 | Ｈｅｒ−２ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009500298A JP2009500298A (ja) | 2009-01-08 |
| JP2009500298A5 true JP2009500298A5 (enExample) | 2009-07-30 |
| JP5222134B2 JP5222134B2 (ja) | 2013-06-26 |
Family
ID=37571268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517193A Expired - Fee Related JP5222134B2 (ja) | 2005-06-15 | 2006-06-15 | Ｈｅｒ−２ペプチド |
| JP2012093680A Expired - Fee Related JP5542865B2 (ja) | 2005-06-15 | 2012-04-17 | Ｈｅｒ−２ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012093680A Expired - Fee Related JP5542865B2 (ja) | 2005-06-15 | 2012-04-17 | Ｈｅｒ−２ペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7691396B2 (enExample) |
| EP (1) | EP1912680B1 (enExample) |
| JP (2) | JP5222134B2 (enExample) |
| AU (1) | AU2006261342B2 (enExample) |
| CA (1) | CA2612394C (enExample) |
| ES (1) | ES2531483T3 (enExample) |
| WO (1) | WO2006138675A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4658423B2 (ja) * | 1999-08-03 | 2011-03-23 | ザ オハイオ ステイト ユニバーシティ | Ｈｅｒ−２タンパク質に対する免疫反応性を増強するためのポリペプチドおよびポリヌクレオチド |
| WO2006138675A2 (en) | 2005-06-15 | 2006-12-28 | The Ohio State University Research Foundation | Her-2 peptides |
| US8945573B2 (en) * | 2005-09-08 | 2015-02-03 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Targeted identification of immunogenic peptides |
| WO2008097229A1 (en) * | 2007-02-09 | 2008-08-14 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services | Method for spectroscopic quantitation of her-2 in biological samples |
| JP5269186B2 (ja) * | 2008-04-22 | 2013-08-21 | ロックウッド・リチウム・インコーポレイテッド | 高純度水酸化リチウムと塩酸とを製造する方法 |
| US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| US9125848B2 (en) | 2010-06-10 | 2015-09-08 | The Cleveland Clinic Foundation | Alpha lactalbumin immunization methods |
| RU2607033C2 (ru) * | 2010-09-28 | 2017-01-10 | Ноно Инк. | Пептиды nd2 и способы лечения неврологического заболевания |
| RU2645085C2 (ru) | 2012-04-16 | 2018-02-15 | Дзе Кливленд Клиник Фаундейшн | Мультивалентная вакцина против рака молочной железы |
| WO2014131019A2 (en) | 2013-02-25 | 2014-08-28 | Ohio State Innovation Foundation | Her-1, her-3 and igf-1r compositions and uses thereof |
| CN105017425B (zh) * | 2014-04-30 | 2018-02-16 | 京天成生物技术(北京)有限公司 | 抗her2中和活性单克隆抗体及其应用 |
| WO2017078761A2 (en) * | 2015-11-06 | 2017-05-11 | Evorx Technologies, Inc. | Her-2-specific cyclized supr peptides |
| WO2018145020A1 (en) | 2017-02-03 | 2018-08-09 | The Medical College Of Wisconsin, Inc. | Kras peptide vaccine compositions and method of use |
| CA3058393A1 (en) * | 2017-03-28 | 2018-10-04 | Ohio State Innovation Foundation | Human pd1 peptide vaccines and uses thereof |
| US20200179500A1 (en) * | 2018-12-05 | 2020-06-11 | Wayne State University | Methods and immunogenic compositions relating to her2 with selective sequence modifications |
| US20220169747A1 (en) * | 2019-03-22 | 2022-06-02 | Olivia Newton-John Cancer Research Institute | Anti-her2 binding molecules |
| AU2020350666A1 (en) * | 2019-09-17 | 2022-03-31 | Ohio State Innovation Foundation | Human anti-PD-L1 peptide vaccines and methods of their use |
| CN119136838A (zh) | 2022-02-28 | 2024-12-13 | 特瑞德姆生物科技有限责任两合公司 | 由至少一种β-葡聚糖或甘露聚糖组成或包含至少一种β-葡聚糖或甘露聚糖的偶联物 |
| CN119019569B (zh) * | 2024-08-19 | 2025-10-24 | 中国人民解放军陆军军医大学 | 一种可定向增强胸腺新生t细胞杀伤乳腺癌的多肽及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989006692A1 (en) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
| EP0474727B1 (en) * | 1989-05-19 | 1997-07-23 | Genentech, Inc. | Her2 extracellular domain |
| CA2074720C (en) * | 1990-01-26 | 2002-07-23 | Martin A. Cheever | Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| IL101943A0 (en) * | 1991-05-24 | 1992-12-30 | Genentech Inc | Structure,production and use of heregulin |
| EP0671948B1 (en) | 1992-06-25 | 1997-08-13 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine composition containing adjuvants |
| AU687750B2 (en) | 1992-09-28 | 1998-03-05 | Wyeth Holdings Corporation | Method of enhancing cell mediated immune responses |
| CA2145391A1 (en) | 1992-09-30 | 1994-04-14 | Vernon C. Stevens | Vaccines and antigenic conjugates |
| US5801005A (en) * | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| US5869445A (en) * | 1993-03-17 | 1999-02-09 | University Of Washington | Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| JP3468773B2 (ja) | 1994-07-15 | 2003-11-17 | ザ ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 免疫調節オリゴヌクレオチド |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US6410022B1 (en) | 1995-05-01 | 2002-06-25 | Avant Immunotherapeutics, Inc. | Modulation of cholesteryl ester transfer protein (CETP) activity |
| NZ331596A (en) * | 1996-04-03 | 1999-07-29 | Pepresearch A S | Non-dendritic backbone peptide carrier |
| CN100415772C (zh) | 1996-10-18 | 2008-09-03 | 基因技术股份有限公司 | 抗ErbB2抗体 |
| CN1181422A (zh) * | 1996-10-31 | 1998-05-13 | 上海市肿瘤研究所 | 与生长因子受体结合的多肽所构建的基因转移载体 |
| AU738338B2 (en) | 1997-08-11 | 2001-09-13 | Allergan, Inc. | Sterile bioerodible implant device with improved biocompatability and method |
| ZA9811162B (en) | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
| EP0953823A2 (en) | 1998-05-01 | 1999-11-03 | Aisin Cosmos R & D Co. Ltd. | Micro yaw rate sensors |
| WO2000034337A1 (en) | 1998-12-10 | 2000-06-15 | Tsukuba Research Laboratory, Toagosei Co., Ltd. | Humanized monoclonal antibodies against vascular endothelial cell growth factor |
| ES2320311T3 (es) * | 1999-05-14 | 2009-05-21 | Genentech, Inc. | Tratamiento con anticuerpos anti-erbb2. |
| JP4658423B2 (ja) * | 1999-08-03 | 2011-03-23 | ザ オハイオ ステイト ユニバーシティ | Ｈｅｒ−２タンパク質に対する免疫反応性を増強するためのポリペプチドおよびポリヌクレオチド |
| US6432409B1 (en) * | 1999-09-14 | 2002-08-13 | Antigen Express, Inc. | Hybrid peptides modulate the immune response |
| US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| PL365789A1 (pl) * | 2000-08-14 | 2005-01-10 | Corixa Corporation | Kompozycje oraz sposoby leczenia i diagnozowania nowotworów związanych z Her-2/neu |
| GB0213878D0 (en) * | 2002-06-17 | 2002-07-31 | Protherics Plc | Use |
| WO2004030616A2 (en) * | 2002-09-17 | 2004-04-15 | Antigen Express, Inc. | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
| AU2004218284B2 (en) * | 2003-03-04 | 2009-07-23 | Intercell Ag | Streptococcus pyogenes antigens |
| ATE463511T1 (de) * | 2003-06-25 | 2010-04-15 | Ottawa Hospital Res Inst | Verwendung von cardiotrophin zur modulation der stammzellenproliferation |
| JP2008500015A (ja) * | 2003-10-29 | 2008-01-10 | ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド | 血管形成ペプチドおよびその使用 |
| WO2005076972A2 (en) * | 2004-02-05 | 2005-08-25 | The Ohio State University Research Foundation | Chimeric vegf peptides |
| SE527089C2 (sv) | 2004-10-19 | 2005-12-20 | Mia Kumm | Anordning och system för ventilation av tunnel vid brand |
| BRPI0519172A2 (pt) * | 2004-12-20 | 2008-12-30 | Ajimoto Kk | proteÍna mutante, polinucleotÍdeo, microorganismo transformado, e, mÉtodos de produzir uma proteÍna mutante, um peptÍdeo, e alfa-l-aspartil-l-fenilalanina-beta-Éster, e de projetar e produzir uma proteÍna mutante |
| WO2006138675A2 (en) | 2005-06-15 | 2006-12-28 | The Ohio State University Research Foundation | Her-2 peptides |
| US20100234283A1 (en) * | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| JP5510272B2 (ja) | 2010-06-21 | 2014-06-04 | 株式会社リコー | 画像形成装置 |
-
2006
- 2006-06-15 WO PCT/US2006/023672 patent/WO2006138675A2/en not_active Ceased
- 2006-06-15 EP EP06785065.1A patent/EP1912680B1/en not_active Not-in-force
- 2006-06-15 CA CA2612394A patent/CA2612394C/en active Active
- 2006-06-15 AU AU2006261342A patent/AU2006261342B2/en not_active Ceased
- 2006-06-15 US US11/424,526 patent/US7691396B2/en active Active
- 2006-06-15 JP JP2008517193A patent/JP5222134B2/ja not_active Expired - Fee Related
- 2006-06-15 ES ES06785065.1T patent/ES2531483T3/es active Active
-
2010
- 2010-02-01 US US12/697,578 patent/US8470333B2/en active Active
-
2012
- 2012-04-17 JP JP2012093680A patent/JP5542865B2/ja not_active Expired - Fee Related
-
2013
- 2013-05-30 US US13/905,996 patent/US9452204B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009500298A5 (enExample) | ||
| JP2014224121A5 (enExample) | ||
| HRP20211318T1 (hr) | Mutirani polipeptidi interleukina-2 | |
| ES2332590T3 (es) | Dimero peptidico. | |
| ES2387685T3 (es) | Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo | |
| RU2016101711A (ru) | Высокостабильный т-клеточный рецептор и способ его получения и применения | |
| JP2016196472A5 (enExample) | ||
| JP2003530074A5 (enExample) | ||
| JP2020519643A5 (enExample) | ||
| JP2016199557A5 (enExample) | ||
| JP2018171063A5 (enExample) | ||
| JP2006526414A5 (enExample) | ||
| JP2017537926A5 (enExample) | ||
| JP2006504653A5 (enExample) | ||
| JP2016512213A5 (enExample) | ||
| JP2016516061A5 (enExample) | ||
| JP2015537044A5 (enExample) | ||
| HRP20190799T1 (hr) | Imunocitokini na bazi il-15 i sushi domene il-15r alfa | |
| JP2016153410A5 (enExample) | ||
| JP2013529078A5 (enExample) | ||
| JP2008508859A5 (enExample) | ||
| JP2014510519A5 (enExample) | ||
| CN112584858A (zh) | 抗原性ospa多肽 | |
| JP2013517783A5 (enExample) | ||
| JP2013121977A5 (enExample) |